What is CareSync?
Founded in 2011, CareSync is a leading provider of software and services dedicated to chronic disease management. The company uniquely combines advanced technology with 24/7 nursing services to enhance care coordination among patients, their families, caregivers, and all healthcare providers. CareSync offers both turnkey Chronic Care Management services and a software-only option, enabling practices of any size to efficiently meet billing requirements for CPT code 99490. Furthermore, its certified technology simplifies the process for providers to achieve Meaningful Use 2 for Data Exchange, Messaging, and Timely Access. At the core of CareSync's mission are patients, who gain access to their health information, actionable goals, and Comprehensive Care Plan tasks, leading to more productive medical appointments and improved health outcomes.
How much funding has CareSync raised?
CareSync has raised a total of $22.3M across 2 funding rounds:
Series A
$4.3M
Series B
$18M
Series A (2014): $4.3M with participation from Tullis Health Investors and Clearwell Group
Series B (2015): $18M led by Greycroft Partners, Tullis Health Investors, Merck Global Health Innovation Fund, Clearwell Group, and Harbert Venture Partners
Key Investors in CareSync
Greycroft Partners
Greycroft Partners is a venture capital firm specializing in internet and mobile markets, leveraging its extensive network to support entrepreneurs in building successful businesses.
Tullis Health Investors
Tullis Health Investors is a private equity firm focused on high-growth, commercial-stage healthcare companies, aiming to build long-term value and impact global health outcomes.
Merck Global Health Innovation Fund
Merck Global Health Innovation Fund, part of the global healthcare company Merck & Co., Inc., invests in innovative solutions across the healthcare spectrum.
What's next for CareSync?
The recent major strategic investment signals a pivotal phase for CareSync, likely enabling accelerated expansion of its service offerings and technological capabilities. This capital infusion is expected to fuel further development in chronic disease management solutions, potentially broadening its reach to new patient populations and healthcare systems. Strategic partnerships and enhanced data analytics are probable avenues for growth, aiming to solidify CareSync's leadership in facilitating seamless care coordination and improving patient outcomes across the healthcare continuum. The company's trajectory suggests a focus on scaling its operations and deepening its impact within the digital health landscape.
See full CareSync company page
